Full-Time

Manufacturing Engineer

Posted on 5/9/2026

Neogen

Neogen

1,001-5,000 employees

Develops and markets food safety tests

No salary listed

East Lansing, MI, USA

In Person

Category
Mechanical Engineering (1)
Required Skills
Six Sigma
Requirements
  • Bachelor's Degree in Engineering (preferably Mechanical, Biochemical, Industrial or Manufacturing Engineering)
  • 4+ years of related experience
  • OR combination of both education and experience
  • 2+ years of experience in a manufacturing environment
  • Understanding of/experience with manufacturing problem solving and process interrogation tools such as Six Sigma, and production flow tools such as LEAN manufacturing
Responsibilities
  • Works cooperatively with R&D, Process Development, Quality, Production, Regulatory, Equipment Engineering, Supply Chain, and Marketing to ensure project success
  • Successfully contributes to both new product development teams and product support, including the following activities: process capability studies, process development, Six Sigma and Value Improvement projects, report preparation and process/test documentation
  • Designs and coordinates standard engineering tests and experiments
  • Designs, procures, and fabricates equipment tooling and fixtures
  • Characterizes the physical and material properties of the components, and optimizes these properties against device performance requirements
  • Performs troubleshooting on new and existing products/process problems as related to design, material, or processes
  • Summarizes, analyzes, and draws conclusions from test results
  • Completes and manages Capital Equipment Request Authorizations
  • Prepares standard reports/documents to communicate results to the technical community
  • May lead cross-functional project teams
  • Identifies, implements, and manages equipment requirements to support production goals
Desired Qualifications
  • 1+ year manufacturing / process engineering experience in rotary converting and/or automated assembly
  • 1 to 2 years of experience with capital project management and justification
  • 1 to 2 years of AutoCAD and Solidworks design
  • SAP experience a plus
  • Proficiency using Microsoft Office

Neogen develops and markets test kits and services to detect a range of safety issues in the food and animal supply chain. Its products help identify foodborne bacteria, natural toxins, and drug residues in animals, and the company divides its offerings into two segments: Food Safety and Animal Safety. Products are delivered as test kits and related services that enable customers to screen and verify safety at various stages from farm to fork. The firm differentiates itself through its scale and geographic reach, a consequence of the 2022 merger with 3M’s food safety business that nearly doubled its size and created a global leader in food safety by expanding product lines and geographic footprint. Neogen’s goal is to ensure the safety of the world’s food supply by providing comprehensive tools and services that detect contaminants and residues across the food and animal industries.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Lansing, Michigan

Founded

1982

Simplify Jobs

Simplify's Take

What believers are saying

  • Food Safety segment grew 4% core with 22.8% EBITDA margins in Q3 FY2026.
  • Genomics sale to Zoetis for $160M reduces debt below 3x EBITDA by 2026-end.
  • GenSelect suite launched March 2026 boosts Hereford breeding insights in Australia.

What critics are saying

  • Animal Safety revenue plunged 20.1% in Q3 FY2026 from supplier shortages.
  • Petrifilm transition by November 2026 triggers supply disruptions and freight cost spikes.
  • Genomics divestiture strips $90M FY2025 revenue, exposing stranded costs immediately.

What makes Neogen unique

  • Neogen pioneered food safety test kits since 1982 founding in Lansing, Michigan.
  • 2022 merger with 3M's food safety business created $5.3B global leader.
  • Launched Guarani Poll DNA test in May 2026 for Australian Brahman hornless breeding.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Neogen who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Relocation Assistance

Employee Referral Bonus

Student Loan Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Professional Development Budget

Conference Attendance Budget

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Wellness Program

Mental Health Support

Gym Membership

Commuter Benefits

Meal Benefits

Phone/Internet Stipend

Home Office Stipend

Legal Services

Employee Discounts

Company Social Events

Company News

The University of Queensland
Apr 30th, 2026
UQ research sharpens new genetic test to breed hornless cattle.

UQ research sharpens new genetic test to breed hornless cattle. 30 April 2026 Australian cattle producers can more accurately determine whether animals in their herd will grow horns, thanks to a new genetic test developed using University of Queensland research. UQ's commercialisation company UniQuest licensed the research to Neogen Corporation, which unveiled its new genetic test at the Australian Brahman Breeders' Association annual conference in Airlie Beach this week. Queensland Alliance for Agriculture and Food Innovation Associate Professor Elizabeth Ross said her team identified a previously undetected variant of the polled, or hornless, gene in Australian cattle. "The Guarani poll test is a specialised genetic test used in cattle breeding to identify the presence of a specific hornless genetic variant in Bos indicus breeds, such as the Australian Brahman," Dr Ross said. "This is the first test able to detect a Guarani poll mutation, which is one of 4 gene variants associated with hornless cattle including Celtic, Friesian and Mongolian." Dr Ross said existing commercial genetic tests detected only 2 of the 4 known hornless or polled mutations. "Cattle producers are increasingly using DNA tests to breed horns out of their cattle herds because polled animals are safer and allow for more welfare-friendly management," Dr Ross said. "University of Queensland know the Pg allele, the variant gene causing horns not to grow on some animals, is out there in the Australian Brahman population because University of Queensland has found it directly in 3 of the 4 herds University of Queensland studied. "This test will finally give producers with hornless cattle more accurate genetic test results and allow them to purposely breed hornless calves." Neogen strategic beef accounts manager Hannah Bourke said it was pleased to partner with UniQuest to deliver the new Guarani Poll DNA test to the Australian market. "We are proud to be able to deliver commercially relevant solutions to industry," Ms Bourke said. UniQuest CEO Dr Dean Moss said it was exciting to see UQ research drive meaningful results for Australian producers. "This test will give Australian cattle producers confidence in their breeding decisions and it's fantastic UQ research has played a vital role in that," Dr Moss said. The test will be available to Australian producers from May 2026. The Poll Guarani allele was originally discovered by Utsunomiya et al in 2019 in cattle in Brazil, and named as Guarani (PG) after the aquifer beneath its assumed region of origin. Researchers at UQ have discovered a previously undetected causal variant of the polled or hornless gene in Australian cattle. 1 April 2026 An analysis of data from northern Australian cattle has identified key regions of the genome that influence traits like fertility, growth and body condition, sometimes all at the same time. 10 March 2026 Media contact. Get the latest from its newsroom.

Yahoo Finance
Apr 13th, 2026
Neogen reports Q3 loss but raises FY2026 guidance to $860M, sells Genomics unit to Zoetis for $160M

Neogen Corporation reported fiscal third-quarter 2026 results with revenue of $211.2 million, down from $221 million year-on-year, and a net loss of $17 million. The company modestly raised full-year 2026 revenue guidance to approximately $857 million to $860 million. Neogen is reshaping its portfolio through strategic moves, including appointing Jennifer Evans Stacey as Chief Legal & Compliance Officer and agreeing to sell its Genomics business to Zoetis for $160 million. The sale will tighten focus on core Food Safety and Animal Safety segments whilst providing funds for debt reduction. Despite the improved guidance and portfolio streamlining efforts, execution risks remain around integration, supply constraints in Animal Safety, and potential stranded costs following divestitures. Analysts project revenue of $869 million and earnings of $113.7 million by 2029.

Yahoo Finance
Apr 9th, 2026
Neogen sees 22.8% margin growth despite Animal Safety revenue dropping 8.7% in Q3

Neogen Corporation reported Q3 2026 results with Food Safety segment achieving 4% core growth and adjusted EBITDA margins expanding to 22.8%. However, Animal Safety revenue declined 8.7% on a core basis due to third-party supplier transitions, raw material shortages and documentation issues. The company is transitioning from regional operations to a unified global selling framework whilst implementing AI-enabled logistics to reduce manual processes. The Petrifilm manufacturing transition remains on schedule for November 2026, with all production equipment validated. Management expects significant free cash flow improvement in fiscal 2027 as capital expenditures subside. The genomics business divestiture, expected to close in Q2 fiscal 2027, should reduce net debt to adjusted EBITDA below 3x by year-end 2026. Global logistics disruptions are driving high single-digit to low double-digit increases in freight costs.

Yahoo Finance
Apr 9th, 2026
Neogen beats Q1 revenue estimates despite 4.4% sales decline, raises full-year guidance to $859M

Neogen, a life sciences company, reported first-quarter results for calendar year 2026 that exceeded revenue expectations, though sales declined 4.4% year on year to $211.2 million. The company's non-GAAP profit of $0.09 per share beat analyst estimates by 68.8%. Neogen raised its full-year revenue guidance to $858.5 million at the midpoint, 0.9% above analyst expectations. Adjusted EBITDA reached $48.2 million with a 22.8% margin, beating estimates by 18.4%. Free cash flow improved to $11.07 million from negative $13.51 million in the prior-year quarter. Despite the quarterly beat, Neogen's recent performance shows annualised revenue declines of 3.2% over the past two years. Analysts project revenue will decline 1.2% over the next 12 months.

Business Wire
Apr 9th, 2026
Neogen raises FY26 revenue guidance to $857M-860M despite Animal Safety supply setbacks

Neogen Corporation reported third quarter fiscal year 2026 revenue of $211.2 million, down 4.4% year-over-year, though core revenue increased 0.1%. The food safety solutions company raised its full-year revenue guidance to $857 million to $860 million, up from previous guidance of $845 million to $855 million. The Food Safety segment grew 2.6% to $156.7 million, with core growth of 4.0%. However, Animal Safety revenue fell 20.1% to $54.5 million due to third-party supplier issues affecting production. Net loss was $17.0 million, or $0.08 per diluted share, compared to a $10.9 million loss in the prior year. Adjusted EBITDA reached $48.2 million with a 22.8% margin, up from 22.0% previously. Neogen is transitioning Petrifilm manufacturing and has agreed to sell its global Genomics business to Zoetis for $160 million.